Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Laurus Labs Limited
LAURUSLABSCurrent price
486 INR
+8.1 INR (+1.69%)
Last closed
476.65 INR
Company
www.lauruslabs.com
ISIN
INE947Q01028
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
National Stock Exchange of India
Capitalization
269 339 344 331 INR
Yield for 12 month
+31.40 %
1Y
3Y
5Y
10Y
15Y
LAURUSLABS
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India. Address: Serene Chambers, Hyderabad, India, 500034
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
47 253.13 INRP/E ratio
203.8163Dividend Yield
0.17 %Current Year
+50 428 954 097 INR
Last Year
+60 430 250 325 INR
Current Quarter
+12 242 013 960 INR
Last Quarter
+11 953 995 981 INR
Current Year
+15 845 489 811 INR
Last Year
+32 675 682 909 INR
Current Quarter
+6 756 767 356 INR
Last Quarter
+3 781 748 910 INR
Key Figures LAURUSLABS
1 year
3 years
5 years
10 years
EBITDA
7 581 104 838 INR
Operating Margin TTM
PE Ratio
203.8163
Return On Assets TTM
2.68 %
PEG Ratio
–
Return On Equity TTM
3.2 %
Wall Street Target Price
47 253.13 INR
Revenue TTM
50 552 704 535 INR
Book Value
77.13 INR
Revenue Per Share TTM
Dividend Share
0.8 INR
Quarterly Revenue Growth YOY
-0.1 %
Dividend Yield
0.17 %
Gross Profit TTM
32 735 707 512 INR
Earnings per share
2.45 INR
Diluted Eps TTM
2.45 INR
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-45.6 %
Profit Margin
2.59 %
Dividend Analytics LAURUSLABS
Dividend growth over 5 years
433 %Continuous growth
–Payout Ratio 5 years average
37 %Dividend History LAURUSLABS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.8
Ex Dividend Date
06.11.2024
Forward Annual Dividend Yield
0.16 %
Last Split Factor
5:1
Payout Ratio
32.92 %
Last Split Date
29.09.2020
Dividend Date
–
Stock Valuation LAURUSLABS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
203.8163
Forward PE
–
Enterprise Value Revenue
5.9115
Price Sales TTM
5.3279
Enterprise Value EBITDA
37.5505
Price Book MRQ
6.5127
Financials LAURUSLABS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LAURUSLABS
For 52 weeks
360.37 INR
517.79 INR
50 Day MA
476.49 INR
Shares Short Prior Month
–
200 Day MA
442.02 INR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart